Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04504942 |
|
Recruitment Status :
Active, not recruiting
First Posted : August 7, 2020
Last Update Posted : July 1, 2022
|
Sponsor:
CytoDyn, Inc.
Collaborator:
Amarex Clinical Research
Information provided by (Responsible Party):
CytoDyn, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | November 7, 2021 |
| Estimated Study Completion Date : | July 15, 2022 |